Clinical Trial Update: Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacodynamic and pharmacokinetic variability of a basal insulin (code 0000-168) in people with diabetes. The trial status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Basal insulin (0000-168)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes | Phase 1 | Status: COMPLETED